First U.S. Testing of Generic Drugs Is Unveiled by FDA

First U.S. Testing of Generic Drugs Is Unveiled by FDA

Dhiraj Singh/Bloomberg

Ranbaxy Laboratories Ltd.'s Simvotin 40 tablets in Mumbai, India, on Feb. 20, 2014. The U.S. is increasing scrutiny of generic drugs made in India, and in the past nine months banned imports from four plants belonging to Ranbaxy Laboratories Ltd. and Wockhardt Ltd.